Methodological considerations in injury burden of disease studies across Europe: a systematic literature review.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
17 08 2022
Historique:
received: 05 04 2022
accepted: 01 08 2022
entrez: 17 8 2022
pubmed: 18 8 2022
medline: 20 8 2022
Statut: epublish

Résumé

Calculating the disease burden due to injury is complex, as it requires many methodological choices. Until now, an overview of the methodological design choices that have been made in burden of disease (BoD) studies in injury populations is not available. The aim of this systematic literature review was to identify existing injury BoD studies undertaken across Europe and to comprehensively review the methodological design choices and assumption parameters that have been made to calculate years of life lost (YLL) and years lived with disability (YLD) in these studies. We searched EMBASE, MEDLINE, Cochrane Central, Google Scholar, and Web of Science, and the grey literature supplemented by handsearching, for BoD studies. We included injury BoD studies that quantified the BoD expressed in YLL, YLD, and disability-adjusted life years (DALY) in countries within the European Region between early-1990 and mid-2021. We retrieved 2,914 results of which 48 performed an injury-specific BoD assessment. Single-country independent and Global Burden of Disease (GBD)-linked injury BoD studies were performed in 11 European countries. Approximately 79% of injury BoD studies reported the BoD by external cause-of-injury. Most independent studies used the incidence-based approach to calculate YLDs. About half of the injury disease burden studies applied disability weights (DWs) developed by the GBD study. Almost all independent injury studies have determined YLL using national life tables. Considerable methodological variation across independent injury BoD assessments was observed; differences were mainly apparent in the design choices and assumption parameters towards injury YLD calculations, implementation of DWs, and the choice of life table for YLL calculations. Development and use of guidelines for performing and reporting of injury BoD studies is crucial to enhance transparency and comparability of injury BoD estimates across Europe and beyond.

Sections du résumé

BACKGROUND
Calculating the disease burden due to injury is complex, as it requires many methodological choices. Until now, an overview of the methodological design choices that have been made in burden of disease (BoD) studies in injury populations is not available. The aim of this systematic literature review was to identify existing injury BoD studies undertaken across Europe and to comprehensively review the methodological design choices and assumption parameters that have been made to calculate years of life lost (YLL) and years lived with disability (YLD) in these studies.
METHODS
We searched EMBASE, MEDLINE, Cochrane Central, Google Scholar, and Web of Science, and the grey literature supplemented by handsearching, for BoD studies. We included injury BoD studies that quantified the BoD expressed in YLL, YLD, and disability-adjusted life years (DALY) in countries within the European Region between early-1990 and mid-2021.
RESULTS
We retrieved 2,914 results of which 48 performed an injury-specific BoD assessment. Single-country independent and Global Burden of Disease (GBD)-linked injury BoD studies were performed in 11 European countries. Approximately 79% of injury BoD studies reported the BoD by external cause-of-injury. Most independent studies used the incidence-based approach to calculate YLDs. About half of the injury disease burden studies applied disability weights (DWs) developed by the GBD study. Almost all independent injury studies have determined YLL using national life tables.
CONCLUSIONS
Considerable methodological variation across independent injury BoD assessments was observed; differences were mainly apparent in the design choices and assumption parameters towards injury YLD calculations, implementation of DWs, and the choice of life table for YLL calculations. Development and use of guidelines for performing and reporting of injury BoD studies is crucial to enhance transparency and comparability of injury BoD estimates across Europe and beyond.

Identifiants

pubmed: 35978333
doi: 10.1186/s12889-022-13925-z
pii: 10.1186/s12889-022-13925-z
pmc: PMC9382747
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1564

Informations de copyright

© 2022. The Author(s).

Références

Accid Anal Prev. 2015 Jul;80:193-200
pubmed: 25912101
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2018 Sep;26(5):271-275
pubmed: 30566802
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Bull World Health Organ. 1994;72(3):429-45
pubmed: 8062401
Accid Anal Prev. 2018 May;114:34-39
pubmed: 28219638
Int J Environ Res Public Health. 2012 Mar;9(3):924-31
pubmed: 22690173
BMJ. 2019 Feb 6;364:l94
pubmed: 31339847
Arch Public Health. 2022 May 20;80(1):142
pubmed: 35590340
Inj Prev. 2020 Oct;26(Supp 1):i12-i26
pubmed: 31915273
Inj Prev. 2020 Oct;26(Supp 1):i83-i95
pubmed: 32079663
Eur J Trauma Emerg Surg. 2020 Oct;46(5):1115-1122
pubmed: 30617403
Inj Prev. 2016 Feb;22(1):3-18
pubmed: 26635210
Arch Public Health. 2020 Dec 31;78(1):137
pubmed: 33384020
Int J Inj Contr Saf Promot. 2006 Jun;13(2):63-70
pubmed: 16707341
BMC Public Health. 2017 Feb 2;17(1):150
pubmed: 28148259
World J Emerg Surg. 2021 Jul 13;16(1):38
pubmed: 34256793
Bull World Health Organ. 2000;78(8):981-94
pubmed: 10994282
Bull World Health Organ. 2008 Feb;86(2):111-7
pubmed: 18297165
Arch Public Health. 2020 Jan 03;78:1
pubmed: 31908777
Popul Health Metr. 2014 Aug 23;12:20
pubmed: 26019690
Arch Public Health. 2022 Mar 24;80(1):91
pubmed: 35331325
Bull World Health Organ. 2007 Jan;85(1):27-34
pubmed: 17242755
J Korean Med Sci. 2019 Feb 27;34(Suppl 1):e69
pubmed: 30923486
Am J Public Health Nations Health. 1968 Aug;58(8):1431-8
pubmed: 5691377
Br J Surg. 2012 Jan;99 Suppl 1:114-21
pubmed: 22441864
Inj Prev. 2020 Oct;26(Supp 1):i125-i153
pubmed: 32839249
Accid Anal Prev. 2013 Jan;50:659-66
pubmed: 22771286
Epidemiol Rev. 2012;34:17-31
pubmed: 22113244
Lancet Neurol. 2019 Jan;18(1):56-87
pubmed: 30497965
Eur J Public Health. 2013 Apr;23(2):195-201
pubmed: 23402806
J Aging Health. 2008 Mar;20(2):159-82
pubmed: 18287327
Inj Prev. 2012 Dec;18(6):413-20
pubmed: 22729161
Inj Prev. 2020 Oct;26(Supp 1):i115-i124
pubmed: 32169973
PLoS Med. 2017 Jul 11;14(7):e1002331
pubmed: 28700588
Inj Prev. 2008 Feb;14(1):5-10
pubmed: 18245308
Cureus. 2020 Mar 12;12(3):e7250
pubmed: 32195068
Osteoporos Int. 2004 Nov;15(11):897-902
pubmed: 15490120
BMC Public Health. 2010 Jan 29;10:45
pubmed: 20113463
Bone. 2020 Feb;131:115156
pubmed: 31760216
Eur J Trauma Emerg Surg. 2021 Apr 12;:
pubmed: 33846831
J Transp Health. 2015 Sep;2(3):423-433
pubmed: 26516622
J Trauma. 2005 Dec;59(6):1283-90; discussion 1290-1
pubmed: 16394898
J Neurotrauma. 2021 May 15;38(10):1411-1440
pubmed: 26537996
Int J Inj Contr Saf Promot. 2015;22(3):232-42
pubmed: 24787004
Inj Prev. 2018 Apr;24(2):142-148
pubmed: 28818961
Accid Anal Prev. 2018 Feb;111:184-192
pubmed: 29223027
BMC Public Health. 2009 Oct 13;9:386
pubmed: 19825170
Inj Prev. 2020 Oct;26(Supp 1):i67-i74
pubmed: 32111726
Bull World Health Organ. 2012 Jul 1;90(7):513-21
pubmed: 22807597
Health Policy Plan. 2000 Sep;15(3):263-9
pubmed: 11012400
BMC Public Health. 2014 Jul 29;14:765
pubmed: 25074692
PLoS One. 2014 Oct 24;9(10):e110905
pubmed: 25343447
Inj Prev. 2020 Oct;26(Supp 1):i27-i35
pubmed: 31915268
Inj Prev. 2020 Oct;26(Supp 1):i96-i114
pubmed: 32332142
Lancet. 2004 Jun 19;363(9426):2032-9
pubmed: 15207953
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Traffic Inj Prev. 2016 Nov 16;17(8):863-9
pubmed: 26979091
Inj Prev. 2020 Oct;26(Supp 1):i36-i45
pubmed: 31857422
Eur J Public Health. 2017 Dec 1;27(6):981-984
pubmed: 28407111
BMC Public Health. 2020 Jan 29;20(1):121
pubmed: 31996206

Auteurs

Periklis Charalampous (P)

Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands. p.charalampous@erasmusmc.nl.

Elena Pallari (E)

Health Innovation Network, Minerva House, Montague Close, London, UK.

Vanessa Gorasso (V)

Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.
Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.

Elena von der Lippe (E)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Brecht Devleesschauwer (B)

Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
Department of Translational Physiology, Infectiology and Public Health, Ghent University, Merelbeke, Belgium.

Sara M Pires (SM)

National Food Institute, Technical University of Denmark, Lyngby, Denmark.

Dietrich Plass (D)

Department for Exposure Assessment, and Environmental Health Indicators, German Environment Agency, Berlin, Germany.

Jane Idavain (J)

Department of Health Statistics, National Institute for Health Development, Tallinn, Estonia.

Che Henry Ngwa (CH)

School of Public Health and Community Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Epidemiology and Population Health, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon.

Isabel Noguer (I)

National School of Public Health, Carlos III Institute of Health, Madrid, Spain.

Alicia Padron-Monedero (A)

National School of Public Health, Carlos III Institute of Health, Madrid, Spain.

Rodrigo Sarmiento (R)

National School of Public Health, Carlos III Institute of Health, Madrid, Spain.
Medicine School, University of Applied and Environmental Sciences, Bogota, Colombia.

Marek Majdan (M)

Department of Public Health, Faculty of Health Sciences and Social Work, Trnava University, Trnava, Slovakia.

Balázs Ádám (B)

Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Ala'a AlKerwi (A)

Directorate of Health, Service Epidemiology and Statistics, Luxembourg, Luxembourg.

Seila Cilovic-Lagarija (S)

Institute for Public Health FB&H, Sarajevo, Sarajevo, Bosnia and Herzegovina.

Benjamin Clarsen (B)

Sports Trauma Research Center, Department of Sports Medicine, Norwegian School of Sport Sciences, Oslo, Norway.
Department of Disease Burden, Norwegian Institute of Public Health, Bergen, Norway.
Department of Health and Functioning, Faculty of Health and Social Sciences, Western Norway University of Applied Sciences, Bergen, Norway.

Barbara Corso (B)

Institute of Neuroscience, National Research Council, Rome, Italy.

Sarah Cuschieri (S)

Department of Anatomy, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.

Keren Dopelt (K)

Department of Public Health, Ashkelon Academic College, Ashkelon, Israel.
Department of Health Policy and Management, School of Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.

Mary Economou (M)

Department of Nursing, School of Health Sciences, Cyprus University of Technology, Limassol, Cyprus.

Florian Fischer (F)

Institute of Public Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Alberto Freitas (A)

CINTESIS - Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, Porto, Portugal.
Department of Community Medicine, Information and Health Decision Sciences (MEDCIDS), Faculty of Medicine, University of Porto, Porto, Portugal.

Juan Manuel García-González (JM)

Department of Sociology, Universidad Pablo de Olavide, Seville, Spain.

Federica Gazzelloni (F)

Institute and Faculty of Actuaries, London, UK.

Artemis Gkitakou (A)

Department of Internal Medicine and Epidemiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Hakan Gulmez (H)

Department of Family Medicine, Faculty of Medicine, İzmir Democracy University, Izmir, Turkey.

Paul Hynds (P)

Environmental Sustainability and Health Institute, Technological University Dublin, Dublin, Ireland.

Gaetano Isola (G)

Department of General Surgery and Surgical-Medical Specialties, School of Dentistry, University of Catania, Catania, Italy.

Lea S Jakobsen (LS)

National Food Institute, Technical University of Denmark, Lyngby, Denmark.

Zubair Kabir (Z)

Public Health & Epidemiology, School of Public Health, University College Cork, Cork, Ireland.

Katarzyna Kissimova-Skarbek (K)

Department of Health Economics and Social Security, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland.

Ann Kristin Knudsen (AK)

Department of Disease Burden, Norwegian Institute of Public Health, Bergen, Norway.

Naime Meriç Konar (NM)

Department of Biostatistics and Medical Informatics, Faculty of Medicine, Kirsehir Ahi Evran University, Kirsehir, Turkey.

Carina Ladeira (C)

H&TRC - Health & Technology Research Center, Escola Superior de Tecnologia da Saúde (ESTeSL), Instituto Politécnico de Lisboa, Lisbon, Portugal.
Comprehensive Health Research Centre (CHRC), Universidade NOVA de Lisboa, Lisbon, Portugal.

Brian Lassen (B)

National Food Institute, Technical University of Denmark, Lyngby, Denmark.

Aaron Liew (A)

Clinical Sciences Institute, School of Medicine, National University of Ireland, Galway, Galway City, Ireland.

Marjeta Majer (M)

Andrija Štampar School of Public Health, School of Medicine, University of Zagreb, Zagreb, Croatia.

Enkeleint A Mechili (EA)

Clinic of Social and Family Medicine, School of Medicine, University of Crete, Crete, Greece.
Department of Healthcare, Faculty of Public Health, University of Vlora, Vlora, Albania.

Alibek Mereke (A)

Al-Farabi Kazakh National University, Almaty, Kazakhstan.

Lorenzo Monasta (L)

Institute of Maternal, Child Health - IRCCS Burlo Garofolo, Trieste, Italy.

Stefania Mondello (S)

Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.

Joana Nazaré Morgado (JN)

Environmental Health and Nutrition Laboratory, Faculty of Medicine, University of Lisbon, Lisbon, Portugal.

Evangelia Nena (E)

Laboratory of Social Medicine, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.

Edmond S W Ng (ESW)

School of Hygiene & Tropical Medicine, London, UK.

Vikram Niranjan (V)

School of Public Health, Physiotherapy and Sport Sciences, University College Dublin, Dublin, Ireland.

Iskra Alexandra Nola (IA)

Andrija Štampar School of Public Health, School of Medicine, University of Zagreb, Zagreb, Croatia.

Rónán O'Caoimh (R)

Department of Geriatric Medicine, Mercy University Hospital, Grenville Place, Cork City, Ireland.

Panagiotis Petrou (P)

Pharmacoepidemiology-Pharmacovigilance, Pharmacy School, School of Sciences and Engineering, University of Nicosia, Nicosia, Cyprus.

Vera Pinheiro (V)

CINTESIS - Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, Porto, Portugal.

Miguel Reina Ortiz (MR)

College of Public Health, University of South Florida, Tampa, FL, USA.

Silvia Riva (S)

Department of Psychology and Pedagogic Science, St Mary's University, London, UK.

Hanen Samouda (H)

Population Health Department, Luxembourg Institute of Health, Nutrition and Health Research Group, Luxembourg, Luxembourg.

João Vasco Santos (JV)

CINTESIS - Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, Porto, Portugal.
Department of Community Medicine, Information and Health Decision Sciences (MEDCIDS), Faculty of Medicine, University of Porto, Porto, Portugal.
Public Health Unit, ACES Grande Porto VIII - Espinho/Gaia, ARS Norte, Lisbon, Portugal.

Cornelia Melinda Adi Santoso (CMA)

Faculty of Public Health, University of Debrecen, Debrecen, Hungary.

Milena Santric Milicevic (MS)

Institute of Social Medicine, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Dimitrios Skempes (D)

Swiss Paraplegic Research, Nottwil, Switzerland.

Ana Catarina Sousa (AC)

Department of Biology, School of Science and Technology, University of Évora, Évora, Portugal.
Comprehensive Health Research Centre (CHRC), University of Évora, Évora, Portugal.

Niko Speybroeck (N)

Institute of Health and Society (IRSS), Université Catholique de Louvain, Brussels, Belgium.

Fimka Tozija (F)

Institute of Public Health of Republic of North Macedonia, Saints Cyril and Methodius University of Skopje, Skopje, North Macedonia.
Faculty of Medicine, Saints Cyril and Methodius University of Skopje, Skopje, North Macedonia.

Brigid Unim (B)

Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore Di Sanità, Rome, Italy.

Hilal Bektaş Uysal (HB)

Department of Internal Medicine, Adnan Menderes University School of Medicine, Aydin, Turkey.

Fabrizio Giovanni Vaccaro (FG)

School of Public Health, Università Vita-Salute San Raffaele, Milan, Italy.

Orsolya Varga (O)

Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Milena Vasic (M)

Faculty of Dentistry Pancevo, University Business Academy in Novi Sad, Pancevo, Serbia.
Institute of Public Health of Serbia Dr Milan Jovanović Batut, Belgrade, Serbia.

Francesco Saverio Violante (FS)

Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Unit of Occupational Medicine, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.

Grant M A Wyper (GMA)

Place and Wellbeing Directorate, Public Health Scotland, Glasgow, Scotland, UK.

Suzanne Polinder (S)

Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Juanita A Haagsma (JA)

Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH